Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
Introduction: G3 NENs are aggressive tumors with limited treatment options. Prognosis is rather poor even with best available platinum-based CT (OS of 11m).
Conference:
Presenting Author:
Authors: Riesco-Martinez M, Capdevila J, Alonso V, Jimenez-Fonseca P, Teulé A,
Keywords: Grade 3 Neuroendocrine Neoplasm, nivolumab, gastroenteropancreatic,
#2896 Comparative Genomic Analysis of High Grade Neuroendocrine Neoplasms across Diverse Organs
Introduction: Grade 3 neuroendocrine neoplasms (G3 NENs), if poorly differentiated, have a median survival of 10-19 months. Little is known regarding biologic differences between G3 NENs from different primary sites, most commonly GI and lung.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Sun T
Authors: Sun T, Van Hummelen P, Martin B, Xia C, Zhao L,
Keywords: grade 3, high grade, neuroendocrine carcinoma, whole exome sequencing, rna-seq, transcriptomics, copy number analysis, sequencing, genomics, poorly differentiated,
#1448 Distribution of T-Cell Infiltrate in G1, G2 and G3 NENs
Introduction: The identification of T-cell infiltrate and the expression of inhibitory molecules in the tumor microenvironment could lend support to the use of immunotherapy in the treatment of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs).
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Milione M
Authors: Milione M, Pellegrinelli A, Centonze G, Dominoni F, Pusceddu S,
#1405 Capecitabine-Temozolomide in G3 Neuroendocrine Neoplasms
Introduction: There is no standard second line treatment for G3 neuroendocrine neoplasms (NENs). The sensitivity to platinum combinations of G3 NENs with a Ki67 < 50% remains unclear.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author:
Authors: Crespo G, Lopez C, Jimenez-Fonseca P, Matos I, Capdevila J,
Keywords: capecitabine, temozolomide, G3 NEN, Ki-67,
Introduction: Neuroendocrine neoplasms (NENs) with a Ki-67 >20% (Grade 3) are classified together as Neuroendocrine Carcinomas (NEC), and are usually considered as poorly differentiated. However Grade (G)3 NENs may be heterogeneous, with some demonstrating a well-differentiated cell morphology.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author:
Authors: Mandair D, O'Leary J, Luong T, Thirlwell C, Meyer T,